Quintiles Transnational Holdings Director Sells $250,000 in Stock (Q)
Quintiles Transnational Holdings (NYSE:Q) Director Michael J. Evanisko sold 5,000 shares of the company’s stock on the open market in a transaction dated Thursday, January 16th. The stock was sold at an average price of $50.00, for a total transaction of $250,000.00. Following the completion of the sale, the director now directly owns 15,400 shares of the company’s stock, valued at approximately $770,000. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Quintiles Transnational Holdings (NYSE:Q) traded down 1.61% during mid-day trading on Friday, hitting $48.98. 763,935 shares of the company’s stock traded hands. Quintiles Transnational Holdings has a one year low of $40.10 and a one year high of $50.00. The stock has a 50-day moving average of $45.62 and a 200-day moving average of $44.29. The company has a market cap of $6.315 billion and a P/E ratio of 32.64.
Quintiles Transnational Holdings (NYSE:Q) last issued its quarterly earnings data on Thursday, October 31st. The company reported $0.54 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.50 by $0.04. The company had revenue of $1.20 billion for the quarter, compared to the consensus estimate of $952.14 million. Quintiles Transnational Holdings’s revenue was up 2.1% compared to the same quarter last year. Analysts expect that Quintiles Transnational Holdings will post $2.06 EPS for the current fiscal year.
Q has been the subject of a number of recent research reports. Analysts at Robert W. Baird raised their price target on shares of Quintiles Transnational Holdings from $3.00 to $55.00 in a research note to investors on Friday, December 20th. Separately, analysts at Deutsche Bank downgraded shares of Quintiles Transnational Holdings from a “buy” rating to a “hold” rating in a research note to investors on Wednesday, November 20th. They now have a $51.00 price target on the stock, down previously from $51.50. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $48.95.
Quintiles Transnational Holdings Inc is a provider of biopharmaceutical development services and commercial outsourcing services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.